• Publications
  • Influence
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
TLDR
The current state of knowledge and the implications for patient care in important topic areas, including coronary artery disease and myocardial infarction, congestive heart failure, cerebrovascular disease, atrial fibrillation, peripheral arterial disease, and sudden cardiac death are defined.
ST-segment elevation in conditions other than acute myocardial infarction.
TLDR
Many conditions other than acute myocardial infarction cause elevation of ST segments on an electrocardiogram and it is important to recognize and differentiate other causes of ST-segment elevation.
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
TLDR
The use of transesophageal echocardiography to guide the management of atrial fibrillation may be considered a clinically effective alternative strategy to conventional therapy for patients in whom elective cardioversion is planned.
Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation
TLDR
Patients with AF who have high and low rates of stroke during treatment with aspirin can be identified and validation of the risk stratification scheme is necessary before it can be applied with confidence to clinical management.
Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
TLDR
Adjusted-dose warfarin markedly reduced ischemic stroke/systemic embolism in high-risk atrial fibrillation patients with stage 3 CKD.
Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography.
TLDR
It is concluded that patients with severe apical-wall-motion abnormalities during acute transmural anterior myocardial infarction are at high risk for left-ventricular thrombosis and this high-risk group can be identified before the development of left-volatile thrombi.
...
...